Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TVT 2019

MVRx ARTO: Technology and Clinical Trial Updates (MAVERIC CE Mark Trial)

Presenter: Bernard Prendergast

June 14, 2019

Presentation EuroPCR 2019

The Mitral Valve Repair Clinical (MAVERIC) trial

Presenter: Simon Redwood

May 21, 2019

Presentation EuroPCR 2018

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Presenter: Simon Redwood

May 24, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

Presenter: Daniel Burkhoff, Samir R. Kapadia, Stephen G. Worthley

November 01, 2017

News Conference News PCR London Valves 2017

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

Shelley Wood

September 26, 2017

Presentation TCT 2015

MVRx ARTO System (Septal Sinus Shortening) and the MAVERIC Trial

Presenter: Steven L. Goldberg, Joachim Schofer, Andrejs Erglis

October 14, 2015

Presentation TCT 2014

Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

Presenter: Francesco Maisano, Gregg W. Stone, Brian K. Whisenant, Andrejs Erglis

September 14, 2014

News Daily News

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

Yael L. Maxwell

March 08, 2012

News Daily News

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Yael L. Maxwell

March 08, 2012

News Daily News

Robot-Assisted PCI Shows Promise in Early Clinical Experience

Caitlin E. Cox

April 29, 2011

Advertisement

MVRx ARTO: Technology and Clinical Trial Updates (MAVERIC CE Mark Trial)

The Mitral Valve Repair Clinical (MAVERIC) trial

The MitrAl ValvE RepaIr Clinical (MAVERIC) EU/AU trial

Pace Quickens for Mitral Device Innovation for Repair, Replacement

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

Live From Denver: TCT 2017, Day Three

First Report of the Six Month Outcomes of the MAVERIC Trial of Transcatheter Annular Reduction Therapy (TART) With the ARTO System for Functional Mitral Regurgitation (FMR)

As Percutaneous Mitral Valve Techniques Advance, Questions Turn to Combinations, Staging

MVRx ARTO System (Septal Sinus Shortening) and the MAVERIC Trial

Initial Results of the Mitral Valve Repair Clinical Trial (MAVERIC Trial) Utilizing Percutaneous Septal Sinus Shortening (The MVRx System) for the Treatment of Functional Mitral Regurgitation

SCIPIO: El Tratamiento con Células Madre Cardíacas Parece Prometedor a la luz de los Resultados Preliminares

SCIPIO: Cardiac Stem Cell Treatment Looks Promising in Early Results

Robot-Assisted PCI Shows Promise in Early Clinical Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content